Press release

GenePlanet enters the Nordic market with acquisition of Life Genomics

15 September 2025

Ljubljana/ Gothenburg, 15.9.2025 – GenePlanet, a leading European provider of genetic testing and non-invasive prenatal testing (NIPT), has acquired Life Genomics, a clinical laboratory based in Gothenburg, Sweden. The move marks a strategic step in GenePlanet’s European growth, expanding the company’s footprint in the Nordic region, a healthcare market renowned for innovation and quality.

Welcoming Life Genomics into the GenePlanet group is an important milestone as we enter the Nordic region,” said Marko Bitenc, CEO of GenePlanet. “By combining our wide portfolio and international experience with Life Genomics’ trusted services, we can offer Nordic patients and healthcare providers even more comprehensive solutions. This also reinforce our role as one of Europe’s leading providers.

Life Genomics’ accredited laboratory in Gothenburg will remain fully operational, continuing to provide trusted services for clinics and patients, while gradually integrating GenePlanet’s broader portfolio of advanced genetic tests.

We are very positive about becoming part of GenePlanet, and thereby strengthening our position as a leading NIPT provider in the Nordic region. It is a strategic development that enables us to take the next step and continue to grow in the Nordic market,” added Göran Jacobsson, CEO of Life Genomics.

About GenePlanet
Headquartered in Ljubljana, Slovenia, GenePlanet is one of Europe’s leading biotechnology companies, offering advanced genetic testing solutions. With more than 17 years of experience and a presence in over 45 countries, GenePlanet collaborates with medical centers, research institutions, laboratories worldwide to provide reliable and clinically relevant solutions for patients and physicians and to make preventive and personalized healthcare a reality for all.

About Life Genomics
About Life Genomics was founded in Gothenburg in 2014 to develop genetic testing offerings for healthcare and the general public. Through its own accredited clinical laboratory, the company has established itself as a leading provider of NIPT in the Nordic region. With modern technology, high-quality analyzes and a close collaboration with healthcare providers, Life Genomics contributes to offering expectant parents the most reliable information possible.

Share this article on